The governmental scientific research institute Riken and the Foundation for Biomedical Research and Innovation won the approval from the panel at the health ministry for their clinical research plan to use iPS cells for retinal regeneration.
The research may start this year after official approval by the minister of health, labor and welfare.
The clinical research comes after Kyoto University professor Shinya Yamanaka co-won the 2012 Nobel Prize in physiology or medicine for his development of iPS cells, which may be used for regenerative medicine and drug development.
Masayo Takahashi, an ophthalmologist who heads Riken’s research team on retinal regeneration at the Riken Center for Development Biology, will serve as head of the clinical study at the foundation’s hospital in Kobe.
The full article is located at Japan Times